Scientists have discovered a new way of treating the virus that makes it more resistant to drugs, making it easier to treat and treat patients.
The research has been published online in the Proceedings of the National Academy of Sciences.
The study found that in mice infected with HIV, the virus’s immune system has changed to better attack proteins that protect cells from the virus’ immune system.
Previous studies have shown that the immune system of mice infected in this way has been damaged by the virus.
The new work found that the protective proteins that were damaged in the previous study are also present in HIV-infected mice.
Scientists believe that these proteins protect the cells from being attacked by the immune systems.
“The new findings provide a molecular basis for designing new anti-HIV drugs to treat the virus in humans,” says co-author Andrew Krumholz, a biomedical engineer at the University of California, Berkeley, and the National Institutes of Health.
Previous research has shown that mice infected to the HIV-1 strain in this study were able to be treated with a new drug called AZT, which is a drug that is approved by the FDA for treatment of HIV.
AZT is not available in the U.S., but Krumhelz says he believes it is feasible to make a pill in the near future.
The drug is made by a company called Medivation, which specializes in producing new medications and vaccines.
“We have the ability to make drugs in a few months and sell them,” Krumhell says.
In this study, the scientists also found that they could block a protein that helps the immune cells fight the virus, a protein called a macrophage-antigen complex.
The macrophages are the specialized immune cells that carry out a wide range of important functions.
Macrophages have also been shown to play a role in protecting the brain from cancer.
Previous work has shown how macrophagers can protect brain cells from tumor cells.
“If you think about the role of macrophaging in the immune response, we think we know a lot about how to block the macrophagic response to the virus,” Kromholz says.
The scientists are also exploring whether blocking macrophagocytes in a person’s immune cells could help people with HIV manage symptoms of the virus and other infections.
“This is an exciting first step toward creating a therapy for the disease, which will help millions of people who live with HIV,” Kramholz adds.
“It also represents a new approach to treatment that has potential to significantly reduce the costs of treating people with the virus.”
The research was supported by the National Institute of Allergy and Infectious Diseases (NIAID), the Howard Hughes Medical Institute, and a U.K. National Institute for Health Research fellowship.
More information about HIV can be found at the NIH.
The Associated Press contributed to this report.